Esthesioneuroblastoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}{{ae}}{{Simrat}}
{{CMG}}{{ae}}{{Simrat}}
==Epidemiology and Demographics==
==Epidemiology and Demographics==
==Incidence==
==Prevalence==
==Age==
Esthesioneuroblastoma commonly affects individuals in a wide range of age groups younger than 90/older than 3 (3-90) years of age. There exists a bimodal peak of occurrence in the third and sixth decades of life.
==Race==
There is no racial predilection to the esthesioneuroblastoma.
==Gender==
Esthesioneuroblastoma affects men and women equally.


* According to the [[BBC]], only 200 cases of the disease have been recorded worldwide in the past two decades.<ref name="titleBBC NEWS | Europe | Tumour womans death not natural">{{cite web |url=http://news.bbc.co.uk/2/hi/europe/7308746.stm |title=Tumour woman's death not natural |accessdate=2008-03-22 |format= |work=BBC News | date=2008-03-21}}</ref>
* A 1997 literature search identified 1,457 cases in the published literature since its discovery in 1924, however 487 were cited in more than one paper, bringing the total of reported cases to 945.<ref name="pmid9252701">{{cite journal |author=Broich G, Pagliari A, Ottaviani F |title=Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924 |journal=Anticancer Res. |volume=17 |issue=4A |pages=2683–706 |year=1997 |pmid=9252701 |doi=}}</ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 21:13, 14 January 2016

Esthesioneuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esthesioneuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esthesioneuroblastoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esthesioneuroblastoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esthesioneuroblastoma epidemiology and demographics

CDC on Esthesioneuroblastoma epidemiology and demographics

Esthesioneuroblastoma epidemiology and demographics in the news

Blogs on Esthesioneuroblastoma epidemiology and demographics

Directions to Hospitals Treating Esthesioneuroblastoma

Risk calculators and risk factors for Esthesioneuroblastoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Template:AeSimrat Sarai, M.D. [2]

Epidemiology and Demographics

Incidence

Prevalence

Age

Esthesioneuroblastoma commonly affects individuals in a wide range of age groups younger than 90/older than 3 (3-90) years of age. There exists a bimodal peak of occurrence in the third and sixth decades of life.

Race

There is no racial predilection to the esthesioneuroblastoma.

Gender

Esthesioneuroblastoma affects men and women equally.

References

Template:Central nervous system tumors

Template:WH Template:WS